Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.
Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.
We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.
In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months. Request Insights
Industrialization has led to an uncertain increase in the environmental pollution, which is giving birth to a number of respiratory diseases such as asthma and COPD (chronic obstructive pulmonary disease). The global market of respiratory inhaler devices is on a high pace due to rapid increasing respiratory diseases. Tens of millions people suffer from lung cancer in U.S due to industrialization which resulted into increased environmental pollution, smoking etc.
In 2015, global revenue generated by respiratory inhaler devices stood at USD 30 billion witnessing a compound annual growth rate of 4.3% over the forecast period i.e. 2016-2023. MDIs (metered dose inhalers) constituted the largest market share among inhalation systems followed by dry powder inhaler which is used for treating cystic fibrosis, a life threatening lung disease. In 2015, MDIs segment accounted for 70% of the global revenue.
North America is anticipated to hold the largest consumer base of respiratory inhaler devices followed by Western Europe. North America and Western Europe collectively accounted 65% of the total respiratory inhaler device market in terms of revenue share by the end of 2015 owing to the increasing environmental pollution due to industrialization and smoking habits which is commonly found among youngsters.
Asia-Pacific is anticipated to be the most attractive market in terms of compound annual growth rate, Asia Pacific market is estimated to project a CAGR of 5% over the forecast period due to increasing prevalence of asthma and COPD among children and the geriatric population.CLICK TO DOWNLOAD FREE SAMPLE REPORT
The immune systems of children and older adults are more prone to chronic respiratory diseases; respiratory inhalers devices are anticipated to experience a huge demand in the near future due to increasing number of respiratory patients. It is concerning that the global asthma patients which are substantial in numbers seem to be increasing rapidly as the world becomes more westernised. Developing countries are more vulnerable to respiratory diseases due to poverty that exacerbates risk factors such as indoor air pollution and tobacco consumption, government of these countries are taking strategic and collaborative actions to diagnose and manage respiratory health problems in their countries.
Increasing health awareness coupled with increasing personal disposable income which will result in increased sending on respiratory problems, this will further surge the demand of respiratory inhaler devices in the upcoming 5-6 years.
On the basis of products offered for respiratory care, the market can be segmented into following segments:-
Nebulizers are further segmented into following categories:-
Global Respiratory Inhaler Device Market is further classified on the basis of region as follows:
The major factors that are driving the global respiratory inhaler device market includes increasing prevalence of respiratory diseases such as asthma, COPD and emphysema, growing need for rescue medication during sudden asthmatic attack and technological advancement in the products.
Industrialization which leads to environmental pollution as well as respiratory problems, feasible inhaler devices available in the market and faster delivery are some of the factors that will boost the demand of respiratory inhaler devices over the forecast period.
Factors such as non-standardized dosage for patients, technical problems in inhaler design and lack of effective drugs for certain respiratory disorders, high cost associated with the product, side effects and complications are some of the factors that are anticipated to restrain market growth over the forecast period.
Overview of the Parent Market
Analyst View
Segmentation
By Regions
Global Respiratory Inhaler Device Market has been studied on countries and regions like:
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in current dynamic environment
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions
Copyright © 2021 Research Nester. All Rights Reserved
